Discovery, Synthesis, And Structure-Based Optimization of a Series of N-(tert-Butyl)-2-(N-arylamido)-2-(pyridin-3-yl) Acetamides (ML188) as Potent Noncovalent Small Molecule Inhibitors of the Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) 3CL Protease

Journal of Medicinal Chemistry - Tập 56 Số 2 - Trang 534-546 - 2013
Jon Jacobs1,2,3, Valerie Grum‐Tokars4, Ya Zhou1,2,3, Mark Turlington1,2,3, S. Adrian Saldanha5, Peter Chase5, Aimee L. Eggler6, Eric S. Dawson1,2,3, Yahira M. Báez-Santos6, Sakshi Tomar6, Anna M. Mielech7, Susan C. Baker7, Craig W. Lindsley8,1,2,3, Peter Hodder5, Andrew D. Mesecar6, Shaun R. Stauffer8,1,2,3
1Department of Pharmacology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States
2Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University Medical Center, Nashville, Tennessee 37232, United States
3Vanderbilt Specialized Chemistry Center for Probe Development (MLPCN), Nashville, Tennessee 37232, United States
4Department of Molecular Pharmacology and Biological Chemistry, Northwestern University, Chicago, Illinois 60607, United States
5Lead Identification Division, Translational Research Institute, Scripps Research Institute Molecular Screening Center, 130 Scripps Way, Jupiter, Florida 33458, United States
6Department of Biological Sciences, Purdue University, 915 West State Street, West Lafayette, Indiana 47907, United States
7Department of Microbiology and Immunology, Loyola University Medical Center, 2160 South First Avenue, Maywood, Illinois 60153, United States
8Department of Chemistry, Vanderbilt University, Nashville, Tennessee 37232, United States

Tóm tắt

Từ khóa


Tài liệu tham khảo

Myint S. H., 1995, The Coronaviridae, 389, 10.1007/978-1-4899-1531-3_18

McIntosh K., 1967, Proc. Natl. Acad. Sci. U.S.A., 57, 933, 10.1073/pnas.57.4.933

Ksiazek T. G., 2003, N. Engl. J. Med., 348, 1953, 10.1056/NEJMoa030781

Drosten C., 2003, N. Engl. J. Med., 348, 1967, 10.1056/NEJMoa030747

Ziebuhr J., 2004, Curr. Opin. Microbiol., 7, 412, 10.1016/j.mib.2004.06.007

Pyrc K., 2007, J. Virol., 81, 3051, 10.1128/JVI.01466-06

Fielding B. C., 2011, Future Microbiol., 6, 153, 10.2217/fmb.10.166

Cui L.-J., 2011, Adv. Virol., 129134

Zaki A. M., 2012, N. Engl. J. Med., 367, 1814, 10.1056/NEJMoa1211721

Yang H., 2006, Curr. Pharm. Des., 12, 4573, 10.2174/138161206779010369

Lai L., 2006, Curr. Pharm. Des., 12, 4555, 10.2174/138161206779010396

Fan K., 2004, J. Biol. Chem., 279, 1637, 10.1074/jbc.M310875200

Thiel V., 2001, J. Virol., 75, 6676, 10.1128/JVI.75.14.6676-6681.2001

Fan K., 2005, Biochem. Biophys. Res. Commun., 329, 934, 10.1016/j.bbrc.2005.02.061

Chuck C. P., 2010, PLoS One, 5, e13197, 10.1371/journal.pone.0013197

Anand K., 2003, Science, 300, 1763, 10.1126/science.1085658

Yang H., 2003, Proc. Natl. Acad. Sci. U.S.A., 100, 13190, 10.1073/pnas.1835675100

Bartlam M., 2005, Curr. Opin. Struct. Biol., 15, 664, 10.1016/j.sbi.2005.10.004

Ghosh A. K., 2006, Annu. Rep. Med. Chem., 41, 183

Jain R. P., 2004, J. Med. Chem., 47, 6113, 10.1021/jm0494873

Ghosh A. K., 2005, J. Med. Chem., 48, 6767, 10.1021/jm050548m

Yang S., 2006, J. Med. Chem., 49, 4971, 10.1021/jm0603926

Zhang J., 2007, J. Med. Chem., 50, 1850, 10.1021/jm061425k

Xue X., 2008, J. Virol., 82, 2515, 10.1128/JVI.02114-07

Akaji K., 2011, J. Med. Chem., 54, 7962, 10.1021/jm200870n

Chen L., 2005, J. Virol., 79, 7095, 10.1128/JVI.79.11.7095-7103.2005

Wu C. Y., 2006, Chem. Biol., 13, 261, 10.1016/j.chembiol.2005.12.008

Blanchard J. E., 2004, Chem. Biol., 11, 1445, 10.1016/j.chembiol.2004.08.011

Ghosh A. K., 2008, Bioorg. Med. Chem. Lett., 18, 5684, 10.1016/j.bmcl.2008.08.082

Chen L. R., 2005, Bioorg. Med. Chem. Lett., 15, 3058, 10.1016/j.bmcl.2005.04.027

Zhang J., 2008, Bioorg. Chem., 36, 229, 10.1016/j.bioorg.2008.01.001

Mukherjee P., 2008, Bioorg. Med. Chem., 7, 4138, 10.1016/j.bmc.2008.01.011

Nguyen T. T., 2011, Bioorg. Med. Chem., 21, 3088, 10.1016/j.bmcl.2011.03.034

Yeung K. S., 2007, Infect. Disord.: Drug Targets, 7, 29

Regnier T., 2009, Bioorg. Med. Chem. Lett., 19, 2722, 10.1016/j.bmcl.2009.03.118

Guterman L., 2011, Chem. Eng. News, 89, 19, 10.1021/cen-v089n036.p019

Turk B., 2006, Nat. Rev. Drug Discovery, 5, 785, 10.1038/nrd2092

Hopkins A. L., 2004, Drug Discovery Today, 9, 430, 10.1016/S1359-6446(04)03069-7

Abad-Zapatero C., 2005, Drug Discovery Today, 10, 464, 10.1016/S1359-6446(05)03386-6

Wu C. Y., 2004, Proc. Natl. Acad. Sci. U.S.A., 101, 10012, 10.1073/pnas.0403596101

For information on the MLPCN and information on how to request probe compounds, such ML188, seehttp://mli.nih.gov/mli/mlpcn/.

Chen S., 2010, Protein Cell, 1, 59, 10.1007/s13238-010-0011-4

Erratum.Protein Cell 2010, 1, 307.

Grum-Tokars V., 2008, Virus Res., 133, 63, 10.1016/j.virusres.2007.02.015

Sun H., 2003, Protein Expr. Purif., 32, 302, 10.1016/j.pep.2003.08.016

McGovern S. L., 2002, J. Med. Chem., 45, 1712, 10.1021/jm010533y

Barretto N., 2005, J. Virol., 79, 15189, 10.1128/JVI.79.24.15189-15198.2005

Ratia K., 2008, Proc. Natl. Acad. Sci. U.S.A., 105, 16119, 10.1073/pnas.0805240105

Ugi I., 1959, Angew. Chem., 71, 386

Dömling A., 2000, Angew. Chem., Int. Ed., 39, 3168, 10.1002/1521-3773(20000915)39:18<3168::AID-ANIE3168>3.0.CO;2-U

For information on MLPCN’s probe compound ancillary screen, see Ricerca LeadProfilingScreen:https://pharmacology.ricerca.com.

Otwinowski Z., 1997, Macromolecular Crystallography, 307, 10.1016/S0076-6879(97)76066-X

CCP4, 1994, Acta Crystallogr., 50, 760

Vagin A., 1997, J. Appl. Crystallogr., 30, 1022, 10.1107/S0021889897006766

Murshudov G. N., 1997, Acta Crystallogr., 53, 240

Emsley P., 2004, Acta Crystallogr., 60, 2126

Painter J., 2006, J. Appl. Crystallogr., 39, 109, 10.1107/S0021889805038987

Painter J., 2005, Acta Crystallogr., 61, 465

Winn M. D., 2001, Acta Crystallogr., 57, 122

Berman H. M., 2000, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235